Results 111 to 120 of about 9,825 (155)

Serum Gremlin 1 Remains Elevated Following Successful Direct-Acting Antiviral Therapy for Chronic Hepatitis C. [PDF]

Viruses
Weigand K, Peschel G, Müller M, Buechler C.   +3 more
europepmc   +1 more source

A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran. [PDF]

Cost Eff Resour Alloc
Jafari M, Mehdizadeh P, Keshavarz K, Teymourzadeh E, Abyazi MA, Alavian SM, Pouria A.   +6 more
europepmc   +1 more source

A Database-Derived Global Overview of HCV Resistance-Associated Substitutions: Characterizing Genotypic, Regional, and Temporal Heterogeneity. [PDF]

Int J Mol Sci
Nunes GTM, Sant'Anna TBF, de Araujo NM.
europepmc   +1 more source

Case Report: HCV-triggered porphyria cutanea tarda in a patient with SEC23B-mutated congenital dyserythropoietic anemia type II. [PDF]

Front Med (Lausanne)
Jin X, Li Y, Liu Y, Jiang X, Zhuang J, Shen M, Chen M.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Sofosbuvir

Reactions Weekly, 2018
  +10 more sources

Sofosbuvir

Reactions Weekly, 2017
  +6 more sources

Sofosbuvir

Reactions Weekly, 2016
  +7 more sources

Ribavirin/sofosbuvir/sofosbuvir/velpatasvir

Reactions Weekly, 2021
openaire   +1 more source